KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
14,280
-120 (-0.83%)
At close: Apr 3, 2025, 3:30 PM KST
KOREA PHARMA Revenue
In the year 2024, KOREA PHARMA had annual revenue of 81.28B KRW, down -2.36%. KOREA PHARMA had revenue of 21.94B in the quarter ending December 31, 2024, with 7.22% growth.
Revenue
81.28B
Revenue Growth
-2.36%
P/S Ratio
1.91
Revenue / Employee
606.55M
Employees
134
Market Cap
155.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 81.28B | -1.96B | -2.36% |
Dec 31, 2023 | 83.24B | 2.21B | 2.73% |
Dec 31, 2022 | 81.03B | 1.45B | 1.83% |
Dec 31, 2021 | 79.58B | 8.07B | 11.28% |
Dec 31, 2020 | 71.51B | 5.37B | 8.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Celltrion | 3,557.30B |
Kia Corporation | 107.45T |
Hanwha Aerospace | 11.24T |